WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2015040089) CO RTI STATIN ANALOGUES FOR THE TREATMENT OF INFLAMMATORY AND/OR IMMUNE DISEASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2015/040089    International Application No.:    PCT/EP2014/069842
Publication Date: 26.03.2015 International Filing Date: 17.09.2014
IPC:
C07K 14/575 (2006.01), C07K 14/655 (2006.01)
Applicants: BCN PEPTIDES S.A. [ES/ES]; Pol. Ind. Els Vinyets. Els Fogars Ctra. Comarcal 244, km. 22 - E-08777 Sant Quinti De Mediona (ES)
Inventors: PONSATI OBIOLS, Berta; (ES).
FERNÁNDEZ CARNEADO, Jimena; (ES).
FARRERA-SINFREU, Josep; (ES).
PARENTE DUEÑA, Antonio; (ES)
Agent: CARVAJAL Y URQUIJO, Isabel; (ES)
Priority Data:
13382361.7 18.09.2013 EP
Title (EN) CO RTI STATIN ANALOGUES FOR THE TREATMENT OF INFLAMMATORY AND/OR IMMUNE DISEASES
(FR) ANALOGUES DE LA CORTISTATINE PERMETTANT LE TRAITEMENT DE MALADIES INFLAMMATOIRES ET/OU D'ORIGINE IMMUNITAIRE
Abstract: front page image
(EN)The invention relates to cortistatin analogues and their uses. The compounds of the invention are peptide ligands with potential application in the diagnosis, prevention or therapy of those pathologies where receptors capable of binding to cortistatin, specific or shared with other molecules such as somatostatin and/or ghrelin (GHSR), are expressed, being in addition more stable in serum than cortistatin.
(FR)L'invention porte sur des analogues de la cortistatine et sur leurs utilisations. Les composés de l'invention sont des ligands peptidiques présentant une application potentielle dans le diagnostic, la prévention ou la thérapie des pathologies où des récepteurs pouvant se lier à la cortistatine, de façon spécifique ou de façon partagée avec d'autres molécules telles que la somatostatine et/ou la ghréline (GHSR), sont exprimés, et ils sont de plus plus stables dans le sérum que la cortistatine.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)